stockrowAlign Technology, Inc.
ALGN Healthcare Medical Instruments & Supplies
Align Technology, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $4.0 billion, up 0.90% from fiscal 2024.
- Revenue
- +1.92%
- EPS
- +143.6%
- Free cash flow
- +8.26%
Quarter to September 2026, against a year earlier
Follow ALGN
Alert me
Align Technology, Inc. (ALGN) Net income
Align Technology, Inc.'s net income for fiscal 2025 was $410.4M, unchanged from fiscal 2024. Over the twelve months to 30 September 2026 it was $491.9M. Over the past ten years it has ranged from $144.0M (fiscal 2015) to $1.8B (fiscal 2020); the current reading is higher than 55% of that period. Align Technology, Inc. ranks 9th of 51 Medical Instruments & Supplies companies by net income.
Net income, annual
Embed this chart
Annual newest first
| Period | Net income | Change |
|---|---|---|
| FY2025 | $410.4M | (2.61%) |
| FY2024 | $421.4M | (5.32%) |
| FY2023 | $445.1M | 23.09% |
| FY2022 | $361.6M | (53.17%) |
| FY2021 | $772.0M | (56.53%) |
| FY2020 | $1.8B | 301.08% |
| FY2019 | $442.8M | 10.63% |
| FY2018 | $400.2M | 72.95% |
| FY2017 | $231.4M | 22.00% |
| FY2016 | $189.7M | 31.71% |
Quarterly newest first
| Period | Net income | Change |
|---|---|---|
| Sep 2026 | $135.0M | 24.70% |
| Jun 2026 | $108.3M | (3.97%) |
| Mar 2026 | $112.8M | (16.93%) |
| Dec 2025 | $135.8M | 139.21% |
| 43 more quarters | Free account |
Against its own ten years
Net income against peers
| Company | Net income |
|---|---|
| COO The Cooper Companies, Inc. compare | $570.3M |
| ALGN Align Technology, Inc. | $491.9M |
| AVTR Avantor, Inc. compare | $337.2M |
| TFX Teleflex Incorporated compare | $304.6M |
| ATR AptarGroup, Inc. compare | $267.9M |
| SOLV Solventum Corporation compare | $156.0M |
| RGEN Repligen Corporation compare | −$11.8M |
| BLCO Bausch + Lomb Corporation compare | −$103.0M |
| BAX Baxter International Inc. compare | −$723.0M |
What Net income is
Net Income tells an investor how much profit a company kept in a period after every cost, interest charge and tax.
Reported line item
More on ALGN
- Revenue
- EPS (diluted)
- EBITDA
- Free cash flow
- Operating cash flow
- Gross margin
- Operating margin
- Net margin
- Free cash flow margin
- P/E ratio
- P/S ratio
- P/B ratio
- Price to free cash flow
- EV/EBITDA
- EV/Sales
- EV/FCF
- Return on equity
- Return on assets
- Return on invested capital
- Debt to equity
- Current ratio
- Total debt
- Shares outstanding
- Book value per share
- Revenue growth
- Piotroski F-score
- Altman Z-score
- Beneish M-score
- The full statement